HealthyNCT07239960
Short-Term Rhodiola Rosea: Effects on Hoops Players' Game Time, Fatigue & Performance
A study testing Rhodiola rosea, L in people with Healthy, run by Beijing Sport University at 1 site in China.
Trial summary
This study aims to evaluate the effects of short-term Rhodiola rosea supplementation on simulated game performance, perceived fatigue, and aerobic capacity in basketball players. Read more about this study
- Who is it for?
- Ages 18 to 25 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- Rhodiola rosea, L
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 48 participants
- Where
- 1 siteChina
- Study dates
- 22 Jun 2024to 20 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Male basketball players aged 18 years or older
- National Level 2 athletes or above with training experience
- Voluntarily participating and providing written informed consent
- Healthy, without chronic diseases, neuromuscular or musculoskeletal disorders, cardiovascular diseases, or diabetes
- Not using other nutritional supplements or alcohol-containing products during the study, and non-smokers
Who cannot join
- Allergy to Rhodiola or study-related substances
- Recent major surgery or injury affecting athletic performance
- Use of antidepressants or stimulant drugs
- Unable to comply with training or intervention requirements during the study
- Any other condition that may compromise safety or data reliability
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Short-term Rhodiola Rosea Supplementation on Simulated Game Time, Perceived Fatigue, and Performance in Basketball Players
This study aims to evaluate the effects of short-term Rhodiola rosea supplementation on simulated game performance, perceived fatigue, and aerobic capacity in basketball players. The participants will include 48 professional male basketball players aged 18-25 years, all from Beijing Sport University and holding at least a national level-2 athlete certification.
The key research questions are as follows:
Read more
Does Rhodiola rosea supplementation improve the total completion time of simulated games? Does it reduce post-simulation heart rate and perceived fatigue while enhancing aerobic capacity (e.g., maximal oxygen uptake) and antioxidant indicators?
To address these questions, researchers will compare the Rhodiola rosea supplementation group (RHO group) with the control group (CTR group). Participants will be required to:
Consume Rhodiola rosea supplements or placebos (empty capsules) daily for 28 consecutive days on an empty stomach.
Complete simulated game tests-including sprints, defensive slides, and layups-with total completion time and heart rate recovery recorded.
Provide blood samples for the measurement of biochemical indicators such as total antioxidant capacity, superoxide dismutase activity, and creatine kinase.
Complete a series of physical fitness tests, including the countermovement jump (CMJ) test, 5-km run, YO-YO Intermittent Recovery Test, and maximal oxygen uptake (VO₂max) test.
Read the detailed description
This study is a randomized, controlled, double-blind clinical trial aimed at evaluating the effects of short-term Rhodiola rosea supplementation on simulated game performance, perceived fatigue, physical fitness indicators, and biochemical parameters in professional basketball players. The study participants included 48 male basketball players from Beijing Sport University, all of whom were national level 2 athletes or above, ensuring a consistent training background and sports experience. The experimental design employed a strict randomization method, dividing participants into a Rhodiola rosea supplementation group (RHO group) and a control group (CTR group), with double-blind measures implemented to minimize potential bias. For example, the RHO group received a daily dose of 2.4 g of Rhodiola rosea extract (containing 0.5 g of salidroside per 100 g of raw material), while the CTR group consumed identical-looking empty capsules. All supplements were administered in a fasted state, twice daily, 30 minutes before breakfast and lunch, accompanied by an equal volume of water to control for placebo effects. Additionally, participants' daily dietary intake, including total calories, carbohydrates, proteins, and fats, was recorded throughout the study period to exclude nutritional factors as potential confounders.
In terms of experimental procedures, participants first completed baseline health assessments and physical measurements, followed by a 28-day supplementation period. Key testing sessions included simulated game testing, physical fitness tests, and blood sample collection. The simulated game test record the total time taken by participants to complete the simulated game, which includes common on-court movements such as sprints, defensive slides, and step-backs. Physical fitness tests covered multiple dimensions: the vertical jump test (CMJ) ; the YO-YO intermittent recovery test; the maximal oxygen uptake (VO₂max) test; the 5 km running test; heart rate monitoring used Polar HR monitors, with data recorded before and after tests to assess fatigue recovery.
Blood sample collection was conducted before the simulated game, with participants fasting for 8-12 hours. Venous blood samples were collected uniformly between 8:00 and 8:30 AM, followed by centrifugation to separate plasma and red blood cells, which were stored at -80°C for subsequent analysis. Biochemical indicators included plasma total antioxidant capacity (TAC) and superoxide dismutase (SOD) activity, malondialdehyde (MDA) concentration, and creatine kinase (CK) activity. Data analysis was performed using SPSS software (version 26) and GraphPad Prism (version 9.0), with continuous variables presented as mean ± standard deviation. Normality was assessed using the Shapiro-Wilk test, and a 2×2 mixed-design ANOVA [group (CTR vs. RHO) × time (pre-test vs. post-test)] was employed to evaluate intervention effects.
- Conditions
- Healthy
- Being tested
- Rhodiola rosea, L, Placebo Comparator
- Keywords
- Rhodiola, Sports Performance, Fatigue, Basketball Players, Exercise Physiology, Physical Performance
- Medical subject headings
- Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rhodiola rosea, LDietary supplement
Also called Golden Root, Arctic Root, R. rosea
Participants in this arm will receive daily capsules containing Rhodiola Rosea for 28 days. The capsules are identical in appearance to placebo capsules. The intervention aims to evaluate the effects of Rhodiola supplementation on basketball players' simulated game performance, sprint times, perceived fatigue, aerobic capacity, and antioxidant markers. Participants will undergo baseline and post-intervention physical fitness assessments, including sprint tests, endurance tests, Countermovement Jump (CMJ), heart rate recovery, and simulated game tasks.
Placebo ComparatorOther
Participants in this arm will receive daily placebo capsules (identical in appearance to Rhodiola capsules) for 28 days. This group serves as a control to compare the effects of Rhodiola supplementation on basketball players' simulated game performance, sprint times, perceived fatigue, aerobic capacity, and antioxidant markers. Participants will complete the same baseline and post-intervention physical fitness assessments as the experimental group.
| Study group | Role | What they receive |
|---|---|---|
| Rhodiola Supplementation Group | Experimental | Participants in this arm will receive daily Rhodiola capsules for 28 days. They will undergo simulated basketball game tests and physical fitness assessments (sprint, endurance, jump tests) before and after the supplementation period. Receives: Dietary Supplement: Rhodiola rosea, L |
| Placebo Control Group | Placebo comparator | Participants in this arm will receive daily placebo capsules (empty capsules identical in appearance to Rhodiola) for 28 days. They will undergo the same simulated basketball game tests and physical fitness assessments (sprint, endurance, jump tests) before and after the intervention period, without knowing their group assignment. Receives: Other: Placebo Comparator |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total completion time of the simulated game
Measured: Baseline and after 28 days of supplementation
Secondary outcomes (11)
Rating of Perceived Exertion (RPE)
Measured: Baseline and after 28 days of supplementation
Heart rate recovery
Measured: Baseline and after 28 days of supplementation
Total distance in the YO-YO intermittent recovery test
Measured: Baseline and after 28 days of supplementation
Countermovement jump (CMJ) height
Measured: Baseline and after 28 days of supplementation
Maximal oxygen uptake (VO₂max)
Measured: Baseline and after 28 days of supplementation
5 km running time
Measured: Baseline and after 28 days of supplementation
Plasma total antioxidant capacity (TAC)
Measured: Baseline and after 28 days of supplementation
Superoxide dismutase (SOD) activity
Measured: Baseline and after 28 days of supplementation
Malondialdehyde (MDA) concentration
Measured: Baseline and after 28 days of supplementation
Creatine kinase (CK) activity
Measured: Baseline and after 28 days of supplementation
BMI(kg/m^2)
Measured: Baseline and after 28 days of supplementation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Nov 2025
- Study start22 Jun 2024
- Primary completion20 Sep 2024
- Study completion20 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This study uses a randomized, double-blind, parallel-group design. Participants are randomly assigned to either the Rhodiola supplementation group or the placebo group, and both groups receive their respective interventions simultaneously for 28 days.
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 48 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beijing Sport University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07239960
- Sponsor's protocol ID
- 2024219H
- Status last verified
- May 2025
- First submitted
- 14 Nov 2025
- Last updated
- 20 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data (IPD) from this study will be made available to other researchers for academic purposes upon reasonable request, following publication of the study results. Data sharing will comply with privacy regulations and institutional guidelines.
Study at a glance
From the registry record, last updated by the sponsor on 20 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Short-term Rhodiola Rosea Supplementation on Simulated Game Time, Perceived Fatigue, and Performance in Basketball Players
- ClinicalTrials.gov ID
- NCT07239960
- Acronym / sponsor ID
- 2024219H
- Conditions
- Healthy
- Keywords
- Rhodiola, Sports Performance, Fatigue, Basketball Players, Exercise Physiology, Physical Performance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 48 participants (actual)
- Lead sponsor
- Beijing Sport UniversityUniversity, hospital or other
- Study start
- 22 Jun 2024 (actual)
- Primary completion
- 20 Sep 2024 (actual)
- Study completion
- 20 Dec 2024 (actual)
- First posted
- 20 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the effects of short-term Rhodiola rosea supplementation on simulated game performance, perceived fatigue, and aerobic capacity in basketball players. The participants will include 48 professional male basketball players aged 18-25 years, all from Beijing Sport University and holding at least a national level-2 athlete certification.
The key research questions are as follows:
Does Rhodiola rosea supplementation improve the total completion time of simulated games? Does it reduce post-simulation heart rate and perceived fatigue while enhancing aerobic capacity (e.g., maximal oxygen uptake) and antioxidant indicators?
To address these questions, researchers will compare the Rhodiola rosea supplementation group (RHO group) with the control group (CTR group). Participants will be required to:
Consume Rhodiola rosea supplements or placebos (empty capsules) daily for 28 consecutive days on an empty stomach.
Complete simulated game tests-including sprints, defensive slides, and layups-with total completion time and heart rate recovery recorded.
Provide blood samples for the measurement of biochemical indicators such as total antioxidant capacity, superoxide dismutase activity, and creatine kinase.
Complete a series of physical fitness tests, including the countermovement jump (CMJ) test, 5-km run, YO-YO Intermittent Recovery Test, and maximal oxygen uptake (VO₂max) test.
Detailed description
This study is a randomized, controlled, double-blind clinical trial aimed at evaluating the effects of short-term Rhodiola rosea supplementation on simulated game performance, perceived fatigue, physical fitness indicators, and biochemical parameters in professional basketball players. The study participants included 48 male basketball players from Beijing Sport University, all of whom were national level 2 athletes or above, ensuring a consistent training background and sports experience. The experimental design employed a strict randomization method, dividing participants into a Rhodiola rosea supplementation group (RHO group) and a control group (CTR group), with double-blind measures implemented to minimize potential bias. For example, the RHO group received a daily dose of 2.4 g of Rhodiola rosea extract (containing 0.5 g of salidroside per 100 g of raw material), while the CTR group consumed identical-looking empty capsules. All supplements were administered in a fasted state, twice daily, 30 minutes before breakfast and lunch, accompanied by an equal volume of water to control for placebo effects. Additionally, participants' daily dietary intake, including total calories, carbohydrates, proteins, and fats, was recorded throughout the study period to exclude nutritional factors as potential confounders.
In terms of experimental procedures, participants first completed baseline health assessments and physical measurements, followed by a 28-day supplementation period. Key testing sessions included simulated game testing, physical fitness tests, and blood sample collection. The simulated game test record the total time taken by participants to complete the simulated game, which includes common on-court movements such as sprints, defensive slides, and step-backs. Physical fitness tests covered multiple dimensions: the vertical jump test (CMJ) ; the YO-YO intermittent recovery test; the maximal oxygen uptake (VO₂max) test; the 5 km running test; heart rate monitoring used Polar HR monitors, with data recorded before and after tests to assess fatigue recovery.
Blood sample collection was conducted before the simulated game, with participants fasting for 8-12 hours. Venous blood samples were collected uniformly between 8:00 and 8:30 AM, followed by centrifugation to separate plasma and red blood cells, which were stored at -80°C for subsequent analysis. Biochemical indicators included plasma total antioxidant capacity (TAC) and superoxide dismutase (SOD) activity, malondialdehyde (MDA) concentration, and creatine kinase (CK) activity. Data analysis was performed using SPSS software (version 26) and GraphPad Prism (version 9.0), with continuous variables presented as mean ± standard deviation. Normality was assessed using the Shapiro-Wilk test, and a 2×2 mixed-design ANOVA [group (CTR vs. RHO) × time (pre-test vs. post-test)] was employed to evaluate intervention effects.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- This study uses a randomized, double-blind, parallel-group design. Participants are randomly assigned to either the Rhodiola supplementation group or the placebo group, and both groups receive their respective interventions simultaneously for 28 days.
| Arm | Type | Receives |
|---|---|---|
| Rhodiola Supplementation Group | Experimental | Dietary Supplement: Rhodiola rosea, LParticipants in this arm will receive daily Rhodiola capsules for 28 days. They will undergo simulated basketball game tests and physical fitness assessments (sprint, endurance, jump tests) before and after the supplementation period. |
| Placebo Control Group | Placebo comparator | Other: Placebo ComparatorParticipants in this arm will receive daily placebo capsules (empty capsules identical in appearance to Rhodiola) for 28 days. They will undergo the same simulated basketball game tests and physical fitness assessments (sprint, endurance, jump tests) before and after the intervention period, without knowing their group assignment. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Male basketball players aged 18 years or older
- National Level 2 athletes or above with training experience
- Voluntarily participating and providing written informed consent
- Healthy, without chronic diseases, neuromuscular or musculoskeletal disorders, cardiovascular diseases, or diabetes
- Not using other nutritional supplements or alcohol-containing products during the study, and non-smokers
Key exclusion criteria (5 listed)
- Allergy to Rhodiola or study-related substances
- Recent major surgery or injury affecting athletic performance
- Use of antidepressants or stimulant drugs
- Unable to comply with training or intervention requirements during the study
- Any other condition that may compromise safety or data reliability
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rhodiola rosea, LAlso: Golden Root, Arctic Root, R. roseaParticipants in this arm will receive daily capsules containing Rhodiola Rosea for 28 days. The capsules are identical in appearance to placebo capsules. The intervention aims to evaluate the effects of Rhodiola supplementation on basketball players' simulated game performance, sprint times, perceived fatigue, aerobic capacity, and antioxidant markers. Participants will undergo baseline and post-intervention physical fitness assessments, including sprint tests, endurance tests, Countermovement Jump (CMJ), heart rate recovery, and simulated game tasks. | Dietary supplement | Rhodiola Supplementation Group |
| Placebo ComparatorParticipants in this arm will receive daily placebo capsules (identical in appearance to Rhodiola capsules) for 28 days. This group serves as a control to compare the effects of Rhodiola supplementation on basketball players' simulated game performance, sprint times, perceived fatigue, aerobic capacity, and antioxidant markers. Participants will complete the same baseline and post-intervention physical fitness assessments as the experimental group. | Other | Placebo Control Group |
Primary outcome
Total completion time of the simulated game
Time frame: Baseline and after 28 days of supplementation
11 secondary outcomes
Rating of Perceived Exertion (RPE)
Time frame: Baseline and after 28 days of supplementation
Heart rate recovery
Time frame: Baseline and after 28 days of supplementation
Total distance in the YO-YO intermittent recovery test
Time frame: Baseline and after 28 days of supplementation
Countermovement jump (CMJ) height
Time frame: Baseline and after 28 days of supplementation
Maximal oxygen uptake (VO₂max)
Time frame: Baseline and after 28 days of supplementation
5 km running time
Time frame: Baseline and after 28 days of supplementation
Plasma total antioxidant capacity (TAC)
Time frame: Baseline and after 28 days of supplementation
Superoxide dismutase (SOD) activity
Time frame: Baseline and after 28 days of supplementation
Malondialdehyde (MDA) concentration
Time frame: Baseline and after 28 days of supplementation
Creatine kinase (CK) activity
Time frame: Baseline and after 28 days of supplementation
BMI(kg/m^2)
Time frame: Baseline and after 28 days of supplementation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Nov 2025.
- Individual participant dataSharing planned: Yes. De-identified individual participant data (IPD) from this study will be made available to other researchers for academic purposes upon reasonable request, following publication of the study results. Data sharing will comply with privacy regulations and institutional guidelines.
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Rhodiola rosea, L in people with Healthy, run by Beijing Sport University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total completion time of the simulated game (time frame: Baseline and after 28 days of supplementation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2025.